Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hollmann

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
The Journal of Experimental Medicine|August 27, 2024
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancerApostolia M Tsimberidou, Farah A Alayli, Kwame Okrah, et al.
Cancer Discovery|December 29, 2020
Metastasis and Immune Evasion from Extracellular cGAMP HydrolysisJun Li, Mercedes A Duran, Ninjit Dhanota, et al.
Science Translational Medicine|July 26, 2023
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouseSusan DeWolf, Yuval Elhanati, Katherine Nichols, et al.
Cancer Immunology Research|June 12, 2025
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell ImmunotherapiesMichael Wichroski, Si-Qi Liu, Lauren M Zasadil, et al.
Nature|December 14, 2022
Ovarian cancer mutational processes drive site-specific immune evasionIgnacio Vázquez-García, Florian Uhlitz, Nicholas Ceglia, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
The Journal of Experimental Medicine|August 27, 2024
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancerApostolia M Tsimberidou, Farah A Alayli, Kwame Okrah, et al.
Cancer Discovery|December 29, 2020
Metastasis and Immune Evasion from Extracellular cGAMP HydrolysisJun Li, Mercedes A Duran, Ninjit Dhanota, et al.
Science Translational Medicine|July 26, 2023
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouseSusan DeWolf, Yuval Elhanati, Katherine Nichols, et al.
Cancer Immunology Research|June 12, 2025
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell ImmunotherapiesMichael Wichroski, Si-Qi Liu, Lauren M Zasadil, et al.
Nature|December 14, 2022
Ovarian cancer mutational processes drive site-specific immune evasionIgnacio Vázquez-García, Florian Uhlitz, Nicholas Ceglia, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, et al.
Pageof 10